Abstract
Iridium(III) complexes have gained great attention in cancer treatment in recent years. In this paper, we designed and synthesized a new iridium(III) complex [Ir(piq)2(DQTT)](PF6) Ir1 (piq = 1-phenylisoquinoline, DQTT = 12-(1,4-dihydroquinoxalin-6-yl)-4,5,9,14-tetraazabenzo[b]triphenylene). The Ir1-loaded PEGylated liposomes (Lipo-Ir1) were prepared using the ethanol injection method. The anticancer activity of the complex and Lipo-Ir1 against SGC-7901 (human gastric adenocarcinoma), A549 (human lung carcinoma), HeLa (human cervical carcinoma), HepG2 (human hepatocellular carcinoma), BEL-7402 (human hepatocellular carcinoma), and normal NIH3T3 (mouse embryonic fibroblasts) was tested by the MTT method. The complex Ir1 shows moderate or low cytotoxicity against the selected cancer cells, whereas the Lipo-Ir1 exhibits high anticancer activity toward the same cancer cells. The apoptosis induced by Lipo-Ir1 was assayed by flow cytometry and Lipo-Ir1 induced apoptosis through increasing intracellular reactive-oxygen species levels, decreasing mitochondrial membrane potential, further promoting cytochrome c release and causing the increase of level of intracellular Ca2+. Western blot was used to detect the changes in Bcl-2 family protein and PI3K/AKT pathway proteins. The cloning experiments demonstrated that the Lipo-Ir1 can effectively inhibit cell proliferation. In vivo experiments, Lipo-Ir1 inhibited tumor growth in xenograft nude mice, and the percentage of tumor growth inhibition in vivo was 75.70%. Overall, the liposomes Lipo-Ir1 exhibits higher anticancer activity than Ir1 under the same conditions. These results indicated that Lipo-Ir1 may be a valuable resource for cancer therapy.
Graphic abstract
Similar content being viewed by others
Abbreviations
- A549:
-
Human lung carcinoma
- AO:
-
Acridine orange
- ATP:
-
Adenosine triphosphate
- BCA:
-
Bicinchoninic acid
- BEL-7402:
-
Human hepatocellular
- bpy:
-
2,2′-Bipyridine
- CCCP:
-
Carbonylcyanide-m-chlorophenylhydrazone
- CHO-HP:
-
Cholest-5-en-3β-ol
- DAPI:
-
2-(4-Amidinophenyl)-6-indolecarbamidine dihydrochloride
- DCHF:
-
2′,7′-Dichloro-3,6-fluorandiol
- DCHF-DA:
-
2′,7′-Dichlorodihydrofluorescein diacetate
- DCF:
-
Dichlorofluorescein
- dmb:
-
4,4′-Dimethyl-2,2′-bipyridine
- dmp:
-
2,9-Dimethyl-1,10-phenanthroline
- DMSO:
-
Dimethylsulfoxide
- DQTT:
-
12-(1,4-Dihydroquinoxalin-6-yl)-4,5,9,14-tetraazabenzo[b]triphenylene
- DSPE-MPEG2000:
-
1,2-Distearoyl-sn-glycero-3-phosphoethanolamine-N-(methoxy(polyethylene glycol)-2000)
- EDTA:
-
Ethylene diamine tetraacetic acid
- EB:
-
Ethidium bromide
- EE:
-
Encapsulation efficiency
- FBS:
-
Fetal bovine serum
- Fluo-3AM:
-
Fluo-3-pentaacetoxymethyl ester
- HeLa:
-
Human cervical cancer
- HepG-2:
-
Human hepatocellular carcinoma
- HPIP:
-
2-(4-Hydroxy)phenylimidazo[4,5-f][1,10]phenanthroline
- JC-1:
-
5,5′,6,6′-Tetrachloro-1,1′,3,3′-tetrethylbenzimidalylcarbocyanine iodide
- MAPK:
-
Mitogen-activated protein kinase
- MG-63:
-
Human osteosarcoma
- MTT:
-
3-(4,5-Dimethylthiazole)-2,5-diphenyltetraazolium bromide
- NIH3T3:
-
Mouse embyonic fibroblast
- PBS:
-
Phosphate buffer saline
- PDI:
-
Polydispersity index
- PEG:
-
Polyethylene glycol
- phen:
-
1,10-Phenanthroline
- PI:
-
Propidium iodide
- piq:
-
1-Phenylisoquinoline
- ppy:
-
2-Phenylpyridine
- PQBD:
-
4-(4,5,9,14-Tetraazabenzo[b]triphenylen-2-yl)benzene-1,2-diamine
- RBCs:
-
Red blood cells
- ROS:
-
Reactive oxygen species
- RPMI:
-
Roswell Park Memorial Institute
- SGC-7901:
-
Human gastric adenocarcinoma
- TBST:
-
20 MM Tris–HCl, 150 mM NaCl, 0.05% Tween 20, pH 8.0
- Tris:
-
Tris(hydroxymethylaminomethane)
- Tween:
-
Polyoxyethy-lene monolaurate sorbaitan
References
Jiao Y, Yin J, He H, Peng X, Gao Q (2018) J Am Chem Soc 140:5882–5885
Shah N, Mohammad AS, Saralkar P, Sprowls SA, Vickers SD, John D, Tallman RM, Lucke-Wold BP, Jarrell KE, Pinti M, Nolan RL, Lockman PR (2018) Pharmacol Res 132:47–68
Feng W, Ding Y, Zong W, Ju S (2019) Clin Chim Acta 496:125–133
Chen W, Zheng R, Zhang S, Zeng H, Xia C, Zuo T, Yang Z, Zou X, He J (2013) Cancer Lett 401:63–71
Suhail Y, Cain MP, Vanaja K, Kurywchak PA, Levchenko Kalluri A, Kshitiz R (2019) Cell Syst 9:109–127
Babu E, Bhuvaneswari J, Mareeswaran PM, Thanasekaran P, Lee HM, Coord S (2019) Chem Rev 380:519–549
Du F, Bai L, He M, Zhang WY, Gu YY, Yin H, Liu YJ (2019) J Inorg Biochem 201:110822
He M, Yi QY, Zhang WY, Bai L, Du F, Gu YY, Liu YJ, Wei P (2019) New J Chem 43:8566–8579
Yi QY, Zhang WY, He M, Du F, Wang XZ, Wang YJ, Gu YY, Bai L, Liu YJ (2019) J Biol Inorg Chem 24:151–169
Zhang LX, Gu YY, Wang YJ, Bai L, Du F, Zhang WY, He M, Liu YJ, Chen YZ (2019) Molecules 24:3129
Bond R, Biver T, Via LD, Guarra F, Hyeraci M, Sissi C, Labella L, Marchetti F, Samaritani S (2020) J Inorg Biochem 202:110874
Correa RS, Bomfim LM, Oliveira KM, Moreira DRM, Soares MBP, Ellena J, Bezerra DP, Batista AA (2019) J Inorg Biochem 198:110751
Chen JC, Zhang Y, Li GD, Peng F, Jie XM, She J, Dongye GZ, Zou ZL, Rong SW, Chen LM (2018) J Biol Inorg Chem 23:261–275
Casells I, Stringer T, Hutton AT, Prince S, Smith GS (2018) J Biol Inorg Chem 23:763–774
Meksawangwong S, Gohil B, Punyain W, Pal R, Kielar F (2019) Inorg Chim Acta 497:119066
Caporale C, Massi M (2018) Coord Chem Rev 363:71–91
Gupta G, Kumari P, Ryu JY, Lee J, Mobin SM, Lee CY (2019) Inorg Chem 58:8587–8595
Gupta G, Cherukommu S, Srinivas G, Lee SW, Mum SH, Jung J, Nagesh N, Lee CY (2018) J Inorg Biochem 189:17–29
Liu Z, Sadler PJ (2014) Acc Chem Res 47:1174–1185
Yu ZS, Zhang YJ, Zhang SM, Jia XL, Zhong GS, Yang YL, Du Q, Li JJ, Liu Z (2019) Cancer Lett 447:75–85
Li JJ, Guo LH, Tian ZZ, Zhang SM, Xu ZS, Han YL, Li RX, Li Y, Liu Z (2018) Inorg Chem 57:13552–13563
Yang YJ, Guo LH, Ge XX, Zhu T, Chen WJ, Zhou HX, Zhao LP, Liu Z (2020) Inorg Chem 59:748–758
Zhang WZ, Zhang FY, Wang YL, Song B, Zhang R, Yuan JL (2017) Inorg Chem 56:1309–1318
Li Y, Wang KN, He L, Ji LN, Mao ZW (2020) J Inorg Biochem 205:110976
Naito K, Yokoi K, Balachandran C, Hisamatsu Y, Aoki S (2019) J Inorg Biochem 199:110785
Zhang C, Lai SH, Yang HH, Xing DG, Zeng CC, Tang B, Wan D, Liu YJ (2017) RSC Adv 7:17752–17762
Bai L, Fei WD, Gu YY, He M, Du F, Zhang WY, Yang LL, Liu YJ (2020) J Inorg Biochem 205:111014
Rubio AR, Fidalgo J, Martin-Vargas J, Pérez-Arneiz C, Alonso-Torre SR, Biver T, Espino G, Busto N, Carcía B (2020) J Inorg Biochem 203:110885
Zhang WY, Wang YJ, Du F, He M, Gu YY, Bai L, Yang LL, Liu YJ (2019) Eur J Med Chem 178:401–416
Wan D, Tang B, Wang YJ, Guo BH, Yin H, Yi QY, Liu YJ (2017) Eur J Med Chem 139:180–190
Tang B, Wan D, Wang YJ, Yi QY, Guo BH, Liu YJ (2018) Eur J Med Chem 145:302–314
Sriraman SK, Salzano G, Sarisozen C, Torchilin V (2016) Eur J Pharm Biopharm 105:40–49
Kolate A, Baradia D, Patil S, Vhora I, Kore G, Misra A, Cont J (2014) Release 192:67–81
Poh S, Chelvam V, Kelderhouse LE, Ayala-Lopez W, Vaitilingam B, Putt KS, Low PS (2007) Nanomedicine 12:2441–2451
Zhang WY, Du F, He M, Bai L, Gu YY, Yang LL, Liu YJ (2019) Eur J Med Chem 178:390–400
Liao CC, Xu DQ, Liu XH, Fang YQ, Yi J, Li XF, Guo BH (2018) Int J Nanomedicine 13:4417–4431
Zhang C, Han BJ, Zeng CC, Lai SH, Li W, Tang B, Wan D, Jiang GB, Liu YJ (2016) J Inorg Biochem 157:62–72
Bilakhiya AK, Tyagi B, Paul P, Natarajan P (2002) Inorg Chem 41:3830–3842
Jaafar-Maalej C, Diab R, Andrieu V, Elaissari A, Fessi H (2010) J Lipo Res 20:228–243
Xiong H, Du S, Ni J, Zhou J, Yao J (2016) Biomaterials 94:70–83
Mosmann T (1983) J Immunol Methods 65:55–63
Wang FX, Chen MH, Lin YN, Zhang H, Tan CP, Ji LN, Mao ZW, Appl ACS (2017) Mater Int 9:42471–42481
Wang C, Jiang L, Wang S, Shi H, Wang J, Wang R, Li Y, Dou Y, Liu Y, Hou G, Ke Y, Liu H (2015) PLoS ONE 10:6
Lu LP, Suo FZ, Feng YL, Song LL, Li Y, Li YJ, Wang KT (2019) Eur J Med Chem 176:1–10
Kannan K, Jain SK (2000) Pathophysiology 7:153–163
Han X, Peng B, Xiao BB, Cao SL, Yang CR, Wang WZ, Wang FC, Li HY, Yuan XL, Shi RF, Liao J, Wang HL, Li J, Xu XZ (2019) Eur J Med Chem 162:586–601
Rodic S, Vincent MD (2018) Int J Cancer 142:440–448
Lanna A, Gomes DC, Muller-Durovic B, McDonnell T, Escors D, Gilroy DW, Lee JH, Karin M, Akbar AN (2017) Nat Immunol 18:354–363
Sun Y, Liu WZ, Liu T, Feng X, Yang N, Zhou HF (2015) J Recept Sig Transd 35:600–604
Wei C, Wang X, Chen M, Ouyang K, Song LS, Cheng H (2008) Nature 457:901–905
Guo Y, Li H, Shi W, Zhang J, Feng J, Yang X, Wang K, Zhang H, Yang L (2017) J Colloid Interf Sci 502:59–66
Guo BH, Liao CC, Fang YQ, Li SQ, Li XF, Lu ZF, Chen YZ (2018) Nanomedicine 13:2851–2866
Jing Z, Sui X, Yao J, Xie J, Jiang L, Zhou Y, Pan H, Han W (2016) Cancer Lett 372:226–238
Mukhopadhyay P, Rajesh M, Hasko G, Hawkins BJ, Madesh M, Pacher P (2007) Nat Protoc 2:2295–2301
Ly JD, Grubb DR, Lawen A (2013) Apoptosis 8:115–128
Chen Z, Tao S, Li X, Zeng X, Zhang M, Yao Q (2019) Artif Cell Nanomed B 47:2213–2220
Hwang JY, Park JH, Kim MJ, Kim WJ, Ha KT, Choi BT, Lee SY, Shin HK (2019) Cancer Lett 443:25–33
Guo R, Li G (2018) Hell J Cardiol 59:323–328
Chong SJF, Lai IXH, Qu J, Hirpara J, Kang J, Swaminathan K, Loh T, Kumar A, Vali S, Abbasi T, Pervaiz S (2019) Cancer Lett 457:151–167
Yap TA, Garrett MD, Walton ML, Raynaud F, De Bono JS, Workman P (2008) Curr Opin Pharmacol 8:393–412
Yi QY, Wan D, Tang B, Wang YJ, Zhang WY, Du F, He M, Liu YJ (2018) Eur J Med Chem 2018(145):338–349
Murugan AK, Munirajan AK, Tsuchida N (2012) Oral Oncol 48:383–392
Ho FM, Lin WW, Chen BC, Chao CM, Yang CR, Lin LY, Lai CC, Liu SH, Lian CS (2006) Cell Signal 18:391–399
Acknowledgements
This work was supported by the National Nature Science Foundation of China (no. 21877018).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that no competing interest exists.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Gu, Y., Wen, H., Zhang, Y. et al. Studies of anticancer activity in vivo and in vitro behaviors of liposomes encapsulated iridium(III) complex. J Biol Inorg Chem 26, 109–122 (2021). https://doi.org/10.1007/s00775-020-01841-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00775-020-01841-9